SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001753939-19-000001
Filing Date
2019-01-17
Accepted
2019-01-17 16:26:05
Documents
1
Period of Report
2019-01-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3982
  Complete submission text file 0001753939-19-000001.txt   5682
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Issuer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MARINA BIOTECH, INC. 4721 EMPEROR BOULEVARD, SUITE 350 DURHAM NC 27703
Business Address
Teague Robert Eric (Reporting) CIK: 0001753939 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-13789 | Film No.: 19531206